Homeepilepsy

  • Positive Ph 1 data for Xenon’s Anti-Epileptic drug presented at Eilat Conference

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Briviact approved by FDA for partial-onset seizures in pediatric epilepsy patients

    • May 15, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New App can improve Epilepsy diagnosis

    • May 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New epilepsy drugs could be derived from Red Sea fungus, new study finds

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Medtronic’s Brain Stimulation Therapy for Refractory Epilepsy

    • May 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Epilepsy has no impact on pregnancy for women, study finds

    • May 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Epilepsy research to find Biomarkers for Treatment of Focal Seizures in patients

    • April 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • UCB to expand epilepsy portfolio with strategic acquisition of Midazolam Nasal Spray from Proximagen

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • GW cannabis-derived epilepsy drug gets positive FDA staff review

    • April 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • 1
  • 2